Immunotherapy: A new target for cancer cure (Review)

Oncol Rep. 2023 May;49(5):100. doi: 10.3892/or.2023.8537. Epub 2023 Mar 31.

Abstract

Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self‑replication and anti‑tumor immune responses, showing potential for cancer therapy. The present review discusses the role of the immune system in the treatment of tumor. The strategies for treating tumors are briefly introduced from aspects of active immunization and passive immunotherapy and the dendritic cell vaccines and oncolytic viruses are highlighted, as well as use of blood group A antigen in the treatment of solid tumors.

Keywords: A blood group antigen; immunotherapy; oncolytic virotherapy; tumor.

Publication types

  • Review

MeSH terms

  • Genetic Therapy
  • Humans
  • Immunotherapy
  • Neoplasms* / pathology
  • Oncolytic Virotherapy*
  • Oncolytic Viruses* / genetics

Grants and funding

The present study was supported by Inner Mongolia Natural Science Foundation Project (grant no. 2021MS08060) and Inner Mongolia Medical University Joint Project (grant no. YKD2021LH068).